How One Scientist-Turned-Founder Is Bridging Drug Discovery With Blockchain
After years working in labs studying the cell cycle and the genetics of human disease, Gennaro D’Urso founded Genetic Networks, a for-profit company focused on drug discovery. As a teenager, D’Urso lost vision in both of his eyes due to a mysterious eye condition. He later received his first corneal transplant, which allowed him to regain 20/20 vision in one of his eyes. This event led him to switch majors from business to science, and he eventually got his Ph.D. in Molecular Genetics.